M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine

Karin M. Knudson(National Institutes of Health), Sofia R. Gameiro(National Institutes of Health)

OncoImmunology

January 15, 2018

10.1080/2162402x.2018.1426519

Cited by 185

Related Papers

Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

|Oncotarget|2013|397

Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells

|Oncotarget|2016|104